Friday Pop Quiz 9/26/2025
In a transplant patient who has developed numerous of these lesions requiring Mohs, discussion with the patients transplant team regarding switching to which of the following medications may reduce risk deloping more of these in the future?
A. Sirolimus
B. Cyclosporine
C. Azathioprine
D. Voriconazole
E. Methotrexate
To find out the correct answer and read the explanation, click …
In a transplant patient who has developed numerous of these lesions requiring Mohs, discussion with the patients transplant team regarding switching to which of the following medications may reduce risk deloping more of these in the future?
A. Sirolimus
B. Cyclosporine
C. Azathioprine
D. Voriconazole
E. Methotrexate
To find out the correct answer and read the explanation, click … 
Serving as a mentor is a valuable role in encouraging and guiding the next generation of dermatologists. However, the great demand for mentorship can leave mentors feeling overwhelmed. So is mentorship even worth a practicing dermatologist’s time? What’s an expert mentor’s advice on how medical students can get the most out of a mentoring relationship?
For a mentor’s perspective on the … 
Cyclophosphamide, an alkylating agent introduced in the 1950s, has long served as a cornerstone therapy in rheumatology and oncology for its potent cytotoxic and immunosuppressive effects. In dermatology, it has been employed as a rescue agent for severe, refractory autoimmune and inflammatory skin diseases, particularly those associated with systemic connective tissue disorders. Its role spans co … 
What is the most common secondary neoplasm identified in this lesion?
A. Melanoma
B. Squamous cell carcinoma
C. Basal cell carcinoma
D. Trichoblastoma
E. Trichilemmoma
F. Poroma
To find out the correct answer and read the explanation, click here.
The image is from The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas.
Brought to you by our brand partner
… 
In the age of immunotherapy, is there a place for hedgehog inhibitors in cutaneous oncology?
ODAC Guest Advisor Dr. Vishal Patel says hedgehog inhibitors are even more important now. Dr. Patel spoke with Next Steps in Derm, in partnership with the ODAC Dermatology Conference, where he outlined scenarios in clinical treatment where hedgehog inhibitors make sense. Learn about the two approved m …